Headquarters
1275 KINNEAR RD, SUITE 111A, COLUMBUS, OH 43212-1180, US
COLUMBUS, OH, US
From the company
Clarametyx Biosciences is a clinical stage biopharmaceutical company committed to developing novel immune-enabling therapies for serious or difficult-to-treat respiratory diseases. Its approach targets bacterial biofilms, the driver of many progressive lung diseases, aiming to modify the course of chronic respiratory disease rather than just manage symptoms. Its investigational agent is CMTX-101, evaluated in a Phase 2a study in cystic fibrosis.
1275 KINNEAR RD, SUITE 111A, COLUMBUS, OH 43212-1180, US
Quantities, certifications, and timing.